Compliance Manager and Dealer Compliance Manager – Italy, Malta and Israel (IMI) at GE Healthcare

Milan, Lombardy, Italy

GE Healthcare Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Medical DevicesIndustries

Requirements

  • Knowledge of applicable laws and regulations (including Legislative Decree 231/2001 and anti-bribery laws), industry codes (including MedTech Europe, Confindustria Dispositivi Medici and Farmindustria), and internal policies (including those governing interactions with healthcare professionals)
  • Ability to maintain and update the Organizational Model 231, including risk mapping, control protocols, and training programs
  • Capability to work with the Surveillance Body (Organismo di Vigilanza) on monitoring, reporting, and other relevant activities
  • Experience monitoring developments in Italian and EU healthcare legislation and industry codes
  • Skills in developing and delivering compliance communication and training programs; tracking attendance/completion of mandatory training
  • Ability to coordinate periodic compliance roundtables, including agenda definition, presentation materials, and meeting minutes
  • Participation in committee meetings for review and approval of interactions with healthcare professionals or institutions (e.g., sponsorships, educational grants)
  • Collaboration with functional colleagues on risk assessments, monitoring, investigations, internal audits, and corrective actions
  • Promotion of open reporting culture and support for ombuds investigators
  • Strong business partnering skills, responding timely and pragmatically to compliance requests, promoting compliance and ethical behavior
  • Knowledge of third-party due diligence processes, compliance training assignment/tracking, and onboarding/renewals for distributors, resellers, and channel partners

Responsibilities

  • Oversee compliance with all applicable laws and regulations (including Legislative Decree 231/2001 and anti-bribery laws), industry codes (including MedTech Europe, Confindustria Dispositivi Medici and Farmindustria), and internal policies (including those governing interactions with healthcare professionals)
  • Maintain and update the Organizational Model 231, including risk mapping, control protocols, and training programs; work with the Surveillance Body (Organismo di Vigilanza) on monitoring, reporting, and other relevant activities
  • Monitor developments in Italian and EU healthcare legislation and industry codes and advise management on implications
  • Develop and deliver compliance communication and training programs for employees, contractors, and third-party partners; track attendance at/completion of any mandatory training
  • Coordinate the preparation of periodic compliance roundtables: defining the agenda in collaboration with relevant stakeholders, preparing presentation materials, and drafting formal meeting minutes
  • Arrange and/or participate in committee meetings relating to the review and approval of certain interactions with healthcare professionals or healthcare institutions (e.g., sponsorships, educational grants, etc.)
  • Collaborate with the Improper Payment Prevention Centre of Excellence to support the development and delivery of compliance training programs for employees, ensuring alignment with regulatory/legal requirements and internal policies
  • Work with functional colleagues and other business stakeholders on risk assessments, monitoring, investigations and/or any internal audit activity, identifying compliance gaps and implementing corrective actions
  • Promote open reporting culture and support ombuds investigators and other colleagues involved in the review and resolution of cases
  • Be a strong business partner by responding in a timely and pragmatic manner to compliance-related requests and promoting a culture of compliance and ethical behaviour
  • Assist with other compliance initiatives as identified
  • Ensure third-party relationships (dealers, distributors, resellers, channel partners) are structured and monitored in accordance with Legislative Decree 231/2001; support integration of channel partner-related risks into the Organizational Model 231
  • Collaborate with the Organismo di Vigilanza to report and address risks arising from third-party interactions
  • Partner with business leadership to assess indirect go-to-market strategies and associated compliance risks, including dealers, distributors

Skills

Compliance Management
Anti-Bribery Laws
Legislative Decree 231/2001
Due Diligence
Compliance Training
Risk Mapping
Organizational Model 231
Healthcare Legislation
EU Regulations
MedTech Europe
Confindustria Dispositivi Medici
Farmindustria

GE Healthcare

Healthcare technology and data analytics provider

About GE Healthcare

GE Healthcare provides a range of healthcare technologies and services aimed at improving patient care. Its main products include imaging systems, mobile diagnostic devices, patient monitoring solutions, and advanced software for data analysis. These products help medical professionals make informed decisions and enhance the efficiency of healthcare delivery. Unlike many competitors, GE Healthcare invests significantly in research and development, allocating $1 billion each year to innovate and enhance its offerings. The company’s goal is to support healthcare providers in delivering better patient outcomes, as evidenced by its technology supporting over 300,000 patients daily and managing 2 billion patient scans each year.

Chicago, IllinoisHeadquarters
1892Year Founded
N/ACompany Stage
Data & Analytics, HealthcareIndustries
10,001+Employees

Risks

Emerging AR technologies increase competition in medical imaging.
Regulatory challenges may delay AI application expansions in healthcare.
Dependence on clinical trial success for new product market positioning.

Differentiation

GE Healthcare invests $1 billion annually in R&D for product innovation.
The company supports over 300,000 patients daily with its healthcare technologies.
GE Healthcare's AIR Recon DL offers 3D motion-insensitive imaging for enhanced MRI quality.

Upsides

Acquisition of Caption Health expands AI-powered ultrasound capabilities.
Successful Phase III trial of [18F]flurpiridaz enhances coronary artery disease detection.
Collaboration with Wayra accelerates digital health innovation in EMEA.

Land your dream remote job 3x faster with AI